Eledon Pharmaceuticals (2TK) Q3 2018 Earnings Report
DE:2TK Q3 2018 EPS Results
- Actual EPS
- -EUR 5.95
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 6.92
DE:2TK Q3 2018 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2018
- Date
- 11/13/2018
- Time
- TBA
- Conference Call
- Tuesday, November 13, 2018
DE:2TK Upcoming Earnings
Eledon Pharmaceuticals's next earnings date is estimated for November 18, 2026, based on past reporting schedules.
Q3 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2TK Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 18, 2026 | 2026 (Q3) | -0.17- | -0.19 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | -0.14-0.24 | -0.12 | -107.69% (-0.13) | |
| May 13, 2026 | 2026 (Q1) | -0.16-0.30 | -0.07 | -312.50% (-0.22) | |
| Mar 19, 2026 | 2025 (Q4) | -0.18-0.10 | -0.57 | 82.81% (+0.47) | |
| Nov 14, 2025 | 2025 (Q3) | -0.22-0.19 | -0.29 | 34.38% (+0.10) | |
| Aug 14, 2025 | 2025 (Q2) | -0.21-0.12 | -0.95 | 87.74% (+0.83) | |
| May 14, 2025 | 2025 (Q1) | -0.24-0.07 | -0.3 | 76.47% (+0.23) | |
| Mar 20, 2025 | 2024 (Q4) | -0.28-0.57 | -0.29 | -100.00% (-0.29) | |
| Nov 12, 2024 | 2024 (Q3) | -0.28-0.29 | -0.31 | 8.57% (+0.03) | |
| Aug 08, 2024 | 2024 (Q2) | -0.27-0.32 | -0.36 | 10.00% (+0.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
